Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 10;12(17):16675-16689.
doi: 10.18632/aging.103795. Epub 2020 Sep 10.

Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China

Affiliations

Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China

Jie Chen et al. Aging (Albany NY). .

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The objective of this study was to determine the clinical course and risk factors for patients showing recurrent SARS-CoV-2 RNA positivity. A total of 1087 COVID-19 patients confirmed by RT-PCR from February 24, 2020 to March 31, 2020 were retrospectively enrolled. Advanced age was significantly associated with mortality. In addition, 81 (7.6%) of the discharged patients tested positive for SARS-CoV-2 RNA during the isolation period. For patients with recurrent RT-PCR positivity, the median duration from illness onset to recurrence was 50 days. Multivariate regression analysis identified elevated serum IL-6, increased lymphocyte counts and CT imaging features of lung consolidation during hospitalization as the independent risk factors of recurrence. We hypothesized that the balance between immune response and virus toxicity may be the underlying mechanism of this phenomenon. For patients with a high risk of recurrence, a prolonged observation and additional preventative measures should be implemented for at least 50 days after illness onset to prevent future outbreaks.

Keywords: COVID-19; SARS-CoV-2; clinical course; coronavirus disease 2019; recurrence; risk factor.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: We declare no conflicts of interest.

Figures

Figure 1
Figure 1
Individual duration of viral shedding and positive SARS-CoV-2 RNA recurrence from illness onset after discharge. The timing and results of RT-PCR examinations for SARS-CoV-2 RNA in details. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. RT-PCR=reverse transcription-polymerase chain reaction.
Figure 2
Figure 2
The median duration of different stages in patients with recurrence of positive SARS-CoV-2 RNA after discharge. (A) The median duration from illness onset to initial RT-PCR confirmation, onset of complete RNA negative status and recurrent RT-PCR positivity after discharge, and from discharge to recurrence. (B) The median duration from initial RT-PCR confirmation to onset of complete RNA negative status and recurrent RT-PCR positivity after discharge, and from onset of complete RNA negative status to recurrence. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. RT-PCR=reverse transcription-polymerase chain reaction.

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, et al., and China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382:727–33. 10.1056/NEJMoa2001017 - DOI - PMC - PubMed
    1. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020. [Epub ahead of print]. 10.1001/jama.2020.1097 - DOI - PubMed
    1. World Health Organization. Novel Coronavirus (2019-nCoV) https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B, Li LJ, Zeng G, et al., and China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382:1708–20. 10.1056/NEJMoa2002032 - DOI - PMC - PubMed
    1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061–69. 10.1001/jama.2020.1585 - DOI - PMC - PubMed